Test Research, Inc.

Informe acción TWSE:3030

Capitalización de mercado: NT$34.5b

Salud financiera de hoja de balance de Test Research

Salud financiera controles de criterios 6/6

Test Research tiene un patrimonio de accionistas total de NT$7.8B y una deuda total de NT$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son NT$9.8B y NT$2.1B respectivamente. El BAIT de Test Research es de NT$2.0B, por lo que su ratio de cobertura de intereses es de -147. Tiene efectivo e inversiones a corto plazo que ascienden a NT$978.4M.

Información clave

0%

Ratio deuda-patrimonio

NT$0

Deuda

Ratio de cobertura de intereses-147x
EfectivoNT$978.36m
PatrimonioNT$7.76b
Total pasivoNT$2.06b
Activos totalesNT$9.83b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Capital Investment Trends At Test Research (TWSE:3030) Look Strong

Oct 17
Capital Investment Trends At Test Research (TWSE:3030) Look Strong

Test Research, Inc.'s (TWSE:3030) Popularity With Investors Under Threat As Stock Sinks 27%

Aug 05
Test Research, Inc.'s (TWSE:3030) Popularity With Investors Under Threat As Stock Sinks 27%

Test Research (TWSE:3030) May Have Issues Allocating Its Capital

Jul 11
Test Research (TWSE:3030) May Have Issues Allocating Its Capital

Test Research (TWSE:3030) Has Announced That Its Dividend Will Be Reduced To NT$3.30

Jun 01
Test Research (TWSE:3030) Has Announced That Its Dividend Will Be Reduced To NT$3.30

Optimistic Investors Push Test Research, Inc. (TWSE:3030) Shares Up 67% But Growth Is Lacking

May 31
Optimistic Investors Push Test Research, Inc. (TWSE:3030) Shares Up 67% But Growth Is Lacking

Test Research, Inc.'s (TWSE:3030) 25% Share Price Surge Not Quite Adding Up

Apr 15
Test Research, Inc.'s (TWSE:3030) 25% Share Price Surge Not Quite Adding Up

Is Test Research, Inc. (TPE:3030) A Smart Choice For Dividend Investors?

Mar 19
Is Test Research, Inc. (TPE:3030) A Smart Choice For Dividend Investors?

With EPS Growth And More, Test Research (TPE:3030) Is Interesting

Mar 01
With EPS Growth And More, Test Research (TPE:3030) Is Interesting

Should You Invest In Test Research (TPE:3030)?

Feb 11
Should You Invest In Test Research (TPE:3030)?

Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Jan 24
Test Research (TPE:3030) Has Compensated Shareholders With A Respectable 70% Return On Their Investment

Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Jan 05
Is Test Research, Inc.'s (TPE:3030) Latest Stock Performance Being Led By Its Strong Fundamentals?

Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Dec 18
Is Test Research, Inc. (TPE:3030) A Good Dividend Stock?

Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

Nov 30
Here's Why I Think Test Research (TPE:3030) Is An Interesting Stock

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$5.6B) de 3030 superan a sus pasivos a corto plazo (NT$1.8B).

Pasivo a largo plazo: Los activos a corto plazo de 3030 (NT$5.6B) superan a sus pasivos a largo plazo (NT$277.2M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 3030 está libre de deudas.

Reducción de la deuda: 3030 no ha tenido ninguna deuda en los últimos 5 años.

Cobertura de la deuda: 3030 no tiene deuda, por lo tanto no necesita estar cubierta por flujo de caja operativo.

Cobertura de intereses: 3030 no tiene deuda, por lo que la cobertura de pagos de intereses no es motivo de preocupación.

Hoja de balance

Descubre empresas con salud financiera

7D

1Y

7D

1Y

7D

1Y